Stroop Test for Parkinson's Disease with Deep Brain Stimulation: A Systematic Review.

Q3 Medicine
Innovations in clinical neuroscience Pub Date : 2022-10-01
Amer Cavalheiro Hamdan, Mariana Drabik Vieira
{"title":"Stroop Test for Parkinson's Disease with Deep Brain Stimulation: A Systematic Review.","authors":"Amer Cavalheiro Hamdan, Mariana Drabik Vieira","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Deep brain stimulation (DBS) is considered an alternative treatment for patients with rapidly developing Parkinson's disease (PD). DBS can cause cognitive changes, and it is necessary to perform an executive assessment before and after DBS to better define the prognosis.</p><p><strong>Objective: </strong>The aim of this study was to analyze the use of the Stroop test for assessment of cognitive functions in patients with PD undergoing DBS.</p><p><strong>Methods: </strong>The systematic review was conducted in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Pubmed, Scopus, PsycInfo, and Web of Science were used as electronic databases. All included studies assessed the cognitive ability of patients with PD undergoing DBS through the application of the Stroop test.</p><p><strong>Results: </strong>Thirty-five articles met the inclusion criteria. Among the studies, there were different formats of Stroop applications. Twenty-three articles presented negative results in relation to the individuals' performances in Stroop, compared to the control groups. The results suggested that there was no correlation between low performance in the test and global cognitive risk for the patients.</p><p><strong>Conclusion: </strong>Patients with DBS declined in Stroop performance and showed impairments in response inhibition and speed. These results are not related to the lack of cognitive security of DBS. The Stroop test can be combined with other cognitive instruments to ensure greater approximation of results with reality measures.</p>","PeriodicalId":13635,"journal":{"name":"Innovations in clinical neuroscience","volume":"19 10-12","pages":"29-34"},"PeriodicalIF":0.0000,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9776780/pdf/icns_19_10-12_29.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Innovations in clinical neuroscience","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Deep brain stimulation (DBS) is considered an alternative treatment for patients with rapidly developing Parkinson's disease (PD). DBS can cause cognitive changes, and it is necessary to perform an executive assessment before and after DBS to better define the prognosis.

Objective: The aim of this study was to analyze the use of the Stroop test for assessment of cognitive functions in patients with PD undergoing DBS.

Methods: The systematic review was conducted in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Pubmed, Scopus, PsycInfo, and Web of Science were used as electronic databases. All included studies assessed the cognitive ability of patients with PD undergoing DBS through the application of the Stroop test.

Results: Thirty-five articles met the inclusion criteria. Among the studies, there were different formats of Stroop applications. Twenty-three articles presented negative results in relation to the individuals' performances in Stroop, compared to the control groups. The results suggested that there was no correlation between low performance in the test and global cognitive risk for the patients.

Conclusion: Patients with DBS declined in Stroop performance and showed impairments in response inhibition and speed. These results are not related to the lack of cognitive security of DBS. The Stroop test can be combined with other cognitive instruments to ensure greater approximation of results with reality measures.

脑深部刺激治疗帕金森病的Stroop试验:一项系统综述。
背景:脑深部刺激(DBS)被认为是快速发展的帕金森病(PD)患者的替代治疗方法。DBS可引起认知变化,有必要在DBS前后进行执行评估,以更好地确定预后。目的:本研究的目的是分析Stroop测试在接受DBS的PD患者认知功能评估中的应用。方法:根据系统评价和荟萃分析首选报告项目(PRISMA)指南进行系统评价。Pubmed、Scopus、PsycInfo和Web of Science被用作电子数据库。所有纳入的研究都通过应用Stroop测试评估了接受DBS的PD患者的认知能力。结果:35篇文章符合入选标准。在这些研究中,有不同格式的Stroop应用程序。与对照组相比,23篇文章对个体在Stroop的表现提出了负面结果。结果表明,测试中的低表现与患者的整体认知风险之间没有相关性。结论:DBS患者的Stroop表现下降,反应抑制和速度受损。这些结果与DBS缺乏认知安全性无关。Stroop测试可以与其他认知工具相结合,以确保结果与现实测量结果更接近。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Innovations in clinical neuroscience
Innovations in clinical neuroscience Medicine-Psychiatry and Mental Health
CiteScore
2.10
自引率
0.00%
发文量
87
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信